Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID, 1498,NBRP Hematology & Blood Biochemistry data,blood albumin amount,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000056,plasma albumin level,,,,0.38,g/l,0.0041,0.01,MMO:0000351,automated plasma albumin analysis,,,"Hitachi, model 7170 ",,,,fasting (for 16 hours),76927,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,blood triglyceride amount,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000548,plasma triglyceride level,,,,0.9605,mmol/l,0.0554,0.1356,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),76933,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,blood hemoglobin amount,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000026,blood hemoglobin level,,,,16.4,g/dl,0.2449,0.6,MMO:0000225,automated cell/particle size/count analysis method,,,"Sysmex, F-800 type",,,,fasting (for 16 hours),76914,fasting (for 16 hours) 41,NBRP Organ Weight data,lung mass,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000097,lung wet weight,,,,0.744,g,0.0212,0.052,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71589,specific pathogen-free condition 41,NBRP Organ Weight data,spleen mass,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000149,spleen weight to body weight ratio,,,,0.221,%,0.0029,0.007,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71598,specific pathogen-free condition 1498,NBRP Hematology & Blood Biochemistry data,erythrocyte size trait,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000038,mean corpuscular volume,,,,63.1,fl,2.0412,5.0,MMO:0000225,automated cell/particle size/count analysis method,,,"Sysmex, F-800 type",,,,fasting (for 16 hours),76916,fasting (for 16 hours) 22,NBRP Body Temperature data,body temperature trait,,RS:0000312,F344/Jcl,male,70 days to 56 days,6,,CMO:0000015,body temperature,,,serial mean,37.7,degrees C,0.1225,0.3,MMO:0000034,digital rectal thermometry,,,,,,,specific pathogen-free condition,74942,specific pathogen-free condition 41,NBRP Organ Weight data,kidney mass,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000140,both kidneys wet weight as percentage of body weight,,,,0.647,%,0.0106,0.026,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71594,specific pathogen-free condition 1498,NBRP Hematology & Blood Biochemistry data,erythrocyte quantity,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000037,hematocrit,,,,55.2,%,0.4899,1.2,MMO:0000225,automated cell/particle size/count analysis method,,,"Sysmex, F-800 type",,,,fasting (for 16 hours),76915,fasting (for 16 hours) 41,NBRP Organ Weight data,brain mass,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000139,brain weight to body weight ratio,,,,0.943,%,0.0204,0.05,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71586,specific pathogen-free condition 41,NBRP Organ Weight data,liver mass,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000141,liver weight as percentage of body weight,,,,3.003,%,0.0196,0.048,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71592,specific pathogen-free condition 14,NBRP Blood Pressure and Heart Rate data,arterial blood pressure trait,,RS:0000312,F344/Jcl,male,70 days to 56 days,6,,CMO:0000004,systolic blood pressure,,,serial mean,136,mmHg,8.9815,22.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74940,specific pathogen-free condition 41,NBRP Organ Weight data,lung mass,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000156,lung weight to body weight ratio,,,,0.396,%,0.0082,0.02,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71590,specific pathogen-free condition 41,NBRP Organ Weight data,liver mass,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000158,liver wet weight,,,,5.647,g,0.1519,0.372,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71591,specific pathogen-free condition 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",liver mass,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0000158,liver wet weight,,,,12.7,g,,,MMO:0000005,post excision weight measurement,,,"method not specified, assumed to be digital scale",,,,control condition,13304,control condition 1498,NBRP Hematology & Blood Biochemistry data,blood creatinine amount,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000537,plasma creatinine level,,,,0.26,mg/dl,0.0082,0.02,MMO:0000354,automated plasma creatinine analysis,,,"Hitachi, model 7170 ",,,,fasting (for 16 hours),76936,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,blood cholesterol amount,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000585,plasma total cholesterol level,,,,48,mg/dl,1.2247,3.0,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),76930,fasting (for 16 hours) 41,NBRP Organ Weight data,adrenal gland mass,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000164,both adrenal glands wet weight,,,,39.6,mg,1.5513,3.8,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71595,specific pathogen-free condition 1498,NBRP Hematology & Blood Biochemistry data,blood glucose amount,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000042,plasma glucose level,,,,167,mg/dl,7.3485,18.0,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),76929,fasting (for 16 hours) 14,NBRP Blood Pressure and Heart Rate data,heart pumping trait,,RS:0000312,F344/Jcl,male,70 days to 56 days,6,,CMO:0000002,heart rate,,,serial mean,462,beats/min,7.3485,18.0,MMO:0000052,tail cuff photoplethysmography,,,"NP-NIBP Monitor MK-2000, Muromachi Kikai Co., Ltd, Japan",,,,specific pathogen-free condition,74941,specific pathogen-free condition 41,NBRP Organ Weight data,brain mass,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000155,brain wet weight,,,,1.768,g,0.0155,0.038,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71585,specific pathogen-free condition 1498,NBRP Hematology & Blood Biochemistry data,blood hemoglobin amount,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000291,mean corpuscular hemoglobin concentration,,,,29.8,g/dl,0.6532,1.6,MMO:0000225,automated cell/particle size/count analysis method,,,"Sysmex, F-800 type",,,,fasting (for 16 hours),76918,fasting (for 16 hours) 41,NBRP Organ Weight data,heart mass,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000069,heart wet weight,,,,0.644,g,0.0204,0.05,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71587,specific pathogen-free condition 41,NBRP Organ Weight data,kidney mass,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000085,both kidneys wet weight,,,,1.216,g,0.0278,0.068,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71593,specific pathogen-free condition 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",body mass,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0000012,body weight,,,,350.7,g,,,MMO:0000016,body weighing method,,,"method not specified, assumed to be digital scale",,,,control condition,13302,control condition 1498,NBRP Hematology & Blood Biochemistry data,blood hemoglobin amount,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000290,mean corpuscular hemoglobin level,,,,18.8,pg,0.3266,0.8,MMO:0000225,automated cell/particle size/count analysis method,,,"Sysmex, F-800 type",,,,fasting (for 16 hours),76917,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,blood HDL cholesterol amount,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000646,plasma high density lipoprotein cholesterol level,,,,30.8,mg/dl,0.8573,2.1,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),76931,fasting (for 16 hours) 41,NBRP Organ Weight data,testis mass,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000175,both testes wet weight,,,,2.633,g,0.0927,0.227,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71599,specific pathogen-free condition 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",testis mass,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0000175,both testes wet weight,,,,6.62,g,,,MMO:0000005,post excision weight measurement,,0,,,,,control condition,65821,control condition 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",prostate mass,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0000652,prostate gland wet weight,,,,0.92,g,,,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,65832,control condition 1498,NBRP Hematology & Blood Biochemistry data,blood LDL cholesterol amount,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000647,plasma low density lipoprotein cholesterol level,,,,4,mg/dl,0.4082,1.0,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),76932,fasting (for 16 hours) 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",prostate integrity trait,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0000943,percentage of study population developing ventral prostate tumorous lesions during a period of time,,,,50,%,,,MMO:0000111,ex vivo light microscopy,,0,,,,,control condition,65824,control condition 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",ventral prostate mass,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0000850,ventral prostate gland wet weight,,,,0.27,g,,,MMO:0000005,post excision weight measurement,,0.0,,,,,control condition,65827,control condition 41,NBRP Organ Weight data,testis mass,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000901,both testes wet weight to body weight ratio,,,,1.402,%,0.0461,0.113,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71600,specific pathogen-free condition 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",prostate integrity trait,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0000884,prostate tumorous lesion number,,,,1.5,,,,MMO:0000111,ex vivo light microscopy,,0,,,,,control condition,65823,control condition 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",prostate integrity trait,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0000899,area of ventral prostate occupied by tumorous lesions to total ventral prostate area ratio,,,,0.25,%,,,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,,,,control condition,67947,control condition 41,NBRP Organ Weight data,spleen mass,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000171,spleen wet weight,,,,0.415,g,0.0061,0.015,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71597,specific pathogen-free condition 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",spleen mass,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0000171,spleen wet weight,,,,2.34,g,,,MMO:0000005,post excision weight measurement,,,"method not specified, assumed to be digital scale",,,,control condition,13306,control condition 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",prostate integrity trait,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0000888,area of individual prostate tumorous lesion,,,,0.22,mm2,,,MMO:0000220,ex vivo light microscopy with digital image analysis,,0,,,,,control condition,65839,control condition 41,NBRP Organ Weight data,adrenal gland mass,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000621,both adrenal glands weight to body weight ratio,,,,21,mg/100g,0.5307,1.3,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71596,specific pathogen-free condition 21,NBRP Body Weight data,body mass,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000012,body weight,,,,198.6,g,4.8582,11.9,MMO:0000017,whole body digital scale,,,,,,,specific pathogen-free condition,70688,specific pathogen-free condition 21,NBRP Body Weight data,body mass,,RS:0000312,F344/Jcl,male,42 days,6,,CMO:0000012,body weight,,,,94.4,g,1.4697,3.6,MMO:0000017,whole body digital scale,,,,,,,specific pathogen-free condition,70687,specific pathogen-free condition 21,NBRP Body Weight data,body mass,,RS:0000312,F344/Jcl,male,35 days,6,,CMO:0000012,body weight,,,,62,g,1.0614,2.6,MMO:0000017,whole body digital scale,,,,,,,specific pathogen-free condition,70686,specific pathogen-free condition 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",testis integrity trait,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0001261,percentage of study population developing testis tumors during a period of time,,testis tumor incidence,,100,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,control condition,65841,control condition 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",testis integrity trait,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0001264,percentage of study population developing bilateral testis tumors during a period of time,,bilateral testis tumor incidence,,88,%,,,MMO:0000111,ex vivo light microscopy,,0.0,necropsy,,,,control condition,67949,control condition 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",kidney integrity trait,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0000940,percentage of study population developing unilateral renal agenesis during a period of time,,,,0,%,,,MMO:0000344,necropsy,,0.0,,,,,control condition,106884,control condition 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",leukocyte integrity trait,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0001267,percentage of study population developing leukemia during a period of time,,leukemia incidence,,25,%,,,MMO:0000111,ex vivo light microscopy,,0,,,,,control condition,66142,control condition 1498,NBRP Hematology & Blood Biochemistry data,blood urea nitrogen amount,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000586,plasma urea nitrogen level,,,,7.1043,mmol/l,0.1166,0.2856,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),76935,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,blood total protein amount,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000054,plasma total protein level,,,,62,mg/ml,0.4082,1.0,MMO:0000356,automated plasma total protein analysis,,,"Hitachi, model 7170 ",,,,fasting (for 16 hours),76926,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,basophil quantity,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000368,blood basophil count to total leukocyte count ratio,,,,0,%,0.0,0.0,MMO:0000145,automated differential white blood cell count test,,,May-Giemsa staining,,,,fasting (for 16 hours),76942,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,blood phosphate amount,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000058,plasma phosphate level,,,,8.5,mg/dl,0.4491,1.1,MMO:0000037,automated blood electrolyte analysis,,,"Hitachi, model 7170 ",,,,fasting (for 16 hours),76937,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,blood coagulation trait,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000210,activated partial thromboplastin time,,,,14.9,s,0.694,1.7,MMO:0000178,automated coagulometer method,,,"Sysmex, CA-3000 type",,,,fasting (for 16 hours),76922,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,blood coagulation trait,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000211,prothrombin time,,,,16.8,s,0.4899,1.2,MMO:0000178,automated coagulometer method,,,"Sysmex, CA-3000 type",,,,fasting (for 16 hours),76921,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,eosinophil quantity,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000369,blood eosinophil count to total leukocyte count ratio,,,,1,%,0.4082,1.0,MMO:0000145,automated differential white blood cell count test,,,May-Giemsa staining,,,,fasting (for 16 hours),76943,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,lymphocyte quantity,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000371,blood lymphocyte count to total leukocyte count ratio,,,,73,%,0.8165,2.0,MMO:0000145,automated differential white blood cell count test,,,May-Giemsa staining,,,,fasting (for 16 hours),76946,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,monocyte quantity,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000374,blood monocyte count to total leukocyte count ratio,,,,0,%,0.0,0.0,MMO:0000145,automated differential white blood cell count test,,,May-Giemsa staining,,,,fasting (for 16 hours),76947,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,blood calcium amount,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000378,total plasma calcium level,,,,10.5,mg/dl,0.0816,0.2,MMO:0000037,automated blood electrolyte analysis,,,"Hitachi, model 7170 ",,,,fasting (for 16 hours),76938,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,blood alkaline phosphatase amount,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000045,plasma alkaline phosphatase activity level,,,,564,IU/l,12.6557,31.0,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),76925,fasting (for 16 hours) 1662,NBRP Urine Volume and Urine Electrolyte data,urine chloride amount,,RS:0000312,F344/Jcl,male,63 days,6,,CMO:0000382,urine chloride level,,,,164,mEq/L,11.431,28.0,MMO:0000177,automated urine analysis,,,,,,,0.9% sodium chloride solution (25 ml/kg) ,94882,0.9% sodium chloride solution (25 ml/kg) 1662,NBRP Urine Volume and Urine Electrolyte data,urine potassium amount,,RS:0000312,F344/Jcl,male,63 days,6,,CMO:0002159,urine potassium excretion rate to body weight ratio,,,,239,uEq/100g/6 hrs,10.6145,26.0,MMO:0000177,automated urine analysis,,,"Analytical intruments, PVA alpha II",,,,0.9% sodium chloride solution (25 ml/kg) ,94881,0.9% sodium chloride solution (25 ml/kg) 1662,NBRP Urine Volume and Urine Electrolyte data,urine chloride amount,,RS:0000312,F344/Jcl,male,63 days,6,,CMO:0002158,urine chloride excretion rate to body weight ratio,,,,382,uEq/100g/6 hrs,15.9217,39.0,MMO:0000177,automated urine analysis,,,,,,,0.9% sodium chloride solution (25 ml/kg) ,94883,0.9% sodium chloride solution (25 ml/kg) 1498,NBRP Hematology & Blood Biochemistry data,erythrocyte quantity,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000025,red blood cell count,,,,0.878,x 10E6 cells/ul,0.0233,0.057,MMO:0000225,automated cell/particle size/count analysis method,,,"Sysmex, F-800 type",,,,fasting (for 16 hours),76913,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,leukocyte quantity,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000027,white blood cell count,,,,3.7,x 1000 cells/ul,0.3674,0.9,MMO:0000225,automated cell/particle size/count analysis method,,,"Sysmex, F-800 type",,,,fasting (for 16 hours),76919,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,platelet quantity,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000029,platelet count,,,,761,x 1000 cells/ul,21.2289,52.0,MMO:0000225,automated cell/particle size/count analysis method,,,"Sysmex, F-800 type",,,,fasting (for 16 hours),76920,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,blood bilirubin amount,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0002334,total plasma bilirubin level,,total plasma bilirubin level,,0.01,mg/dl,0.0041,0.01,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),76934,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,blood sodium amount,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000060,plasma sodium level,,,,145.4,mmol/l,0.4491,1.1,MMO:0000037,automated blood electrolyte analysis,,,"Analytical intruments, PVA alpha II",,,,fasting (for 16 hours),76939,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,blood potassium amount,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000061,plasma potassium level,,,,4.49,mmol/l,0.2245,0.55,MMO:0000037,automated blood electrolyte analysis,,,"Analytical intruments, PVA alpha II",,,,fasting (for 16 hours),76940,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,blood chloride amount,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000059,plasma chloride level,,,,106,mmol/l,0.4082,1.0,MMO:0000037,automated blood electrolyte analysis,,,"Analytical intruments, PVA alpha II",,,,fasting (for 16 hours),76941,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,blood aspartate transaminase amount,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000043,plasma aspartate aminotransferase activity level,,,,77,U/l,2.4495,6.0,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),76923,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,blood alanine transaminase amount,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000044,plasma alanine aminotransferase activity level,,,,39,U/l,1.633,4.0,MMO:0000553,automated plasma analysis,,,PMID:15591307,,,,fasting (for 16 hours),76924,fasting (for 16 hours) 1662,NBRP Urine Volume and Urine Electrolyte data,urine potassium amount,,RS:0000312,F344/Jcl,male,63 days,6,,CMO:0000128,urine potassium level,,,,102.1,mmol/l,6.1237,15.0,MMO:0000177,automated urine analysis,,,"Analytical intruments, PVA alpha II",,,,0.9% sodium chloride solution (25 ml/kg) ,94880,0.9% sodium chloride solution (25 ml/kg) 1662,NBRP Urine Volume and Urine Electrolyte data,urine sodium amount,,RS:0000312,F344/Jcl,male,63 days,6,,CMO:0000129,urine sodium level,,,,143.2,mmol/l,7.3076,17.9,MMO:0000177,automated urine analysis,,,"Analytical intruments, PVA alpha II",,,,0.9% sodium chloride solution (25 ml/kg) ,94878,0.9% sodium chloride solution (25 ml/kg) 1662,NBRP Urine Volume and Urine Electrolyte data,urine output,,RS:0000312,F344/Jcl,male,63 days,6,,CMO:0000260,timed urine volume,,,,18.88,ml/d,1.682,4.12,MMO:0000511,metabolic cage urine volume measurement method,,,,,,,0.9% sodium chloride solution (25 ml/kg) ,94876,0.9% sodium chloride solution (25 ml/kg) 1662,NBRP Urine Volume and Urine Electrolyte data,urine sodium amount,,RS:0000312,F344/Jcl,male,63 days,6,,CMO:0001855,urine sodium excretion rate to body weight ratio,,,,0.00938,uEq/min/g,4.0E-4,9.0E-4,MMO:0000177,automated urine analysis,,,"Analytical intruments, PVA alpha II",,,,0.9% sodium chloride solution (25 ml/kg) ,94879,0.9% sodium chloride solution (25 ml/kg) 1662,NBRP Urine Volume and Urine Electrolyte data,urine output,,RS:0000312,F344/Jcl,male,63 days,6,,CMO:0001968,timed urine volume to body weight ratio,,,,0.0672,ul/min/g,0.0057,0.014,MMO:0000511,metabolic cage urine volume measurement method,,,,,,,0.9% sodium chloride solution (25 ml/kg) ,94877,0.9% sodium chloride solution (25 ml/kg) 1498,NBRP Hematology & Blood Biochemistry data,neutrophil quantity,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0002337,blood segmented neutrophil count to total leukocyte count ratio,,segmented neutrophil %,,26,%,1.2247,3.0,MMO:0000145,automated differential white blood cell count test,,,May-Giemsa staining,,,,fasting (for 16 hours),76945,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,blood albumin amount,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0002342,plasma albumin to plasma total protein ratio,,plasma albumin to plasma total protein ratio,,1.53,,0.0163,0.04,MMO:0000352,automated plasma protein analysis,,,"Hitachi, model 7170 ",,,,fasting (for 16 hours),76928,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,leukocyte quantity,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0002339,non-specified leukocyte count to total leukocyte count ratio,,unidentified differential wbc,,0,%,0.0,0.0,MMO:0000145,automated differential white blood cell count test,,,May-Giemsa staining,,,,fasting (for 16 hours),76948,fasting (for 16 hours) 1498,NBRP Hematology & Blood Biochemistry data,neutrophil quantity,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0002338,blood band neutrophil count to total leukocyte count ratio,,band neutrophil %,,0,%,0.0,0.0,MMO:0000145,automated differential white blood cell count test,,,May-Giemsa staining,,,,fasting (for 16 hours),76944,fasting (for 16 hours) 41,NBRP Organ Weight data,heart mass,,RS:0000312,F344/Jcl,male,70 days,6,,CMO:0000074,heart weight to body weight ratio,,,,3.43,g/kg,0.1102,0.27,MMO:0000006,Shimadzu electronic balance post excision weight measurement,,,,,,,specific pathogen-free condition,71588,specific pathogen-free condition 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",prostate integrity trait,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0003687,percentage of study population developing ventral prostate tumorous lesions with a solid structure during a period of time,,,,25,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,control condition,109886,control condition 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",prostate integrity trait,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0003693,number of ventral prostate tumorous lesions with solid structure,,,,0.4,,0.2475,0.7,MMO:0000111,ex vivo light microscopy,,0.0,,,,,control condition,109888,control condition 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",prostate integrity trait,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0003689,area of individual ventral prostate tumorous lesion with a solid structure,,,,0.06,mm2,0.0495,0.14,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,,,,control condition,109890,control condition 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",prostate integrity trait,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0003691,area of ventral prostate occupied by tumorous lesions with solid structure to total ventral prostate area ratio,,,,0.07,%,0.053,0.15,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,,,,control condition,109892,control condition 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",prostate integrity trait,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0003688,"percentage of study population developing ventral prostate tumorous lesions with round, irregular size nuclei during a period of time",,,,38,%,,,MMO:0000111,ex vivo light microscopy,,0.0,,,,,control condition,109958,control condition 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",prostate integrity trait,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0003694,"number of ventral prostate tumorous lesions with round, irregular size nuclei",,,,1.3,,0.6364,1.8,MMO:0000111,ex vivo light microscopy,,0.0,,,,,control condition,109960,control condition 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",prostate integrity trait,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0003690,"area of individual ventral prostate tumorous lesion with round, irregular size nuclei",,,,0.22,mm2,0.1061,0.3,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,,,,control condition,109962,control condition 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",prostate integrity trait,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0003692,"area of ventral prostate occupied by tumorous lesions with round, irregular size nuclei to total ventral prostate area ratio",,,,0.24,%,0.1167,0.33,MMO:0000220,ex vivo light microscopy with digital image analysis,,0.0,,,,,control condition,109964,control condition 341,"Yamashita S, et al., Cancer Res 2005 Apr 1;65(7):2610-6.",hypodermis integrity trait,,RS:0000312,F344/Jcl,male,900 days,8,,CMO:0003387,percentage of study population developing subcutaneous tumors during a period of time,,CMO:0003387 percentage of study population developing subcutaneous tumors during a period of time,,38,%,,,MMO:0000344,necropsy,,0.0,,,,,control condition,106886,control condition